array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(26) "Bio-RAD Laboratories, Inc."
["slug"]=>
string(33) "001cd-us-bio-rad-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920"
["description"]=>
string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics"
["address_street"]=>
string(20) "1000 Alfred Nobel Dr"
["address_place"]=>
string(8) "Hercules"
["address_region"]=>
string(10) "California"
["founding_date"]=>
string(10) "1952-02-08"
["website_domain"]=>
string(11) "bio-rad.com"
["website_url"]=>
string(23) "https://www.bio-rad.com"
["industry_codes"]=>
array(3) {
[0]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
[1]=>
string(33) "Laboratory Analytical Instruments"
[2]=>
string(47) "Electromedical and Electrotherapeutic Apparatus"
}
["employee_count"]=>
int(7900)
["article_count"]=>
int(661)
}
["articles"]=>
array(5) {
[0]=>
array(7) {
["title_en"]=>
string(56) "Bio-Rad Attorney Wins $11 Million in Whistleblower Trial"
["snippet_en"]=>
string(226) "A federal jury Monday awarded the former general counsel of Bio-Rad Laboratories $8 million in back pay and damages — which will increase to $11 million — for whistleblower retaliation involving potential bribery in China."
["url"]=>
string(86) "https://www.courthousenews.com/biorad-attorney-wins-11-million-in-whistleblower-trial/"
["image_url"]=>
NULL
["source"]=>
string(18) "courthousenews.com"
["publication_date"]=>
string(10) "2023-11-10"
["categories"]=>
array(11) {
[0]=>
string(10) "Misconduct"
[1]=>
string(7) "Scandal"
[2]=>
string(15) "Corporate Fines"
[3]=>
string(7) "Bribery"
[4]=>
string(15) "Business Ethics"
[5]=>
string(20) "Corporate Governance"
[6]=>
string(19) "Economic Conditions"
[7]=>
string(8) "Verdicts"
[8]=>
string(24) "Quarterly/Annual Figures"
[9]=>
string(5) "Legal"
[10]=>
string(16) "Case Settlements"
}
}
[1]=>
array(7) {
["title_en"]=>
string(77) "IT & Admin Services to Indian Affiliate by Singapore Entity Not FTS: Delhi HC"
["snippet_en"]=>
string(194) "Delhi High Court rules on income tax and administrative services provided by a Singapore entity to its Indian affiliate. Analysis of the case Commissioner of Income Tax vs. Bio-Rad Laboratories."
["url"]=>
string(99) "https://taxguru.in/income-tax/it-admin-services-indian-affiliate-singapore-entity-fts-delhi-hc.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/24a4d8e8-44c2-4c96-a182-8547617532ae"
["source"]=>
string(10) "taxguru.in"
["publication_date"]=>
string(10) "2023-11-10"
["categories"]=>
array(7) {
[0]=>
string(11) "Legislation"
[1]=>
string(15) "Business Ethics"
[2]=>
string(5) "Taxes"
[3]=>
string(10) "Tax Havens"
[4]=>
string(5) "Legal"
[5]=>
string(46) "Management of Legal and Regulatory Environment"
[6]=>
string(11) "Tax evasion"
}
}
[2]=>
array(7) {
["title_en"]=>
string(56) "Bio-Rad whistleblower case heads back to court on appeal"
["snippet_en"]=>
string(248) "A federal appeals court panel dealt the former general counsel for Bio-Rad Laboratories( NYSE: BIO) a blow, slicing his$ 11 million jury award by$6 million and sending his whistleblower retaliation lawsuit back to U.S. District Court for a possible"
["url"]=>
string(84) "https://www.massdevice.com/bio-rad-whistleblower-case-heads-back-to-court-on-appeal/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/758a7214-8029-43be-a6e9-961d80264c7f"
["source"]=>
string(14) "massdevice.com"
["publication_date"]=>
string(10) "2019-02-27"
["categories"]=>
array(6) {
[0]=>
string(7) "Scandal"
[1]=>
string(15) "Business Ethics"
[2]=>
string(8) "Verdicts"
[3]=>
string(5) "Legal"
[4]=>
string(46) "Management of Legal and Regulatory Environment"
[5]=>
string(10) "Litigation"
}
}
[3]=>
array(7) {
["title_en"]=>
string(104) "Anti-antibody anybody? Bio-Rad range to target Lucentis biosimilar developers - BioProcess International"
["snippet_en"]=>
string(243) "Bio-Rad has launched a range of anti-ranibizumab antibodies for PK and immunogenicity assays on the back of increased Lucentis biosimilar development. Bio-Rad Laboratories will offer customers a range of recombinant monoclonal anti-ranibizumab"
["url"]=>
string(123) "https://bioprocessintl.com/bioprocess-insider/anti-antibody-anybody-bio-rad-range-to-target-lucentis-biosimilar-developers/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/57397ac8-8406-4100-be17-055089035db0"
["source"]=>
string(18) "bioprocessintl.com"
["publication_date"]=>
string(10) "2018-08-07"
["categories"]=>
array(1) {
[0]=>
string(15) "Business Ethics"
}
}
[4]=>
array(7) {
["title_en"]=>
string(56) "SEC Charges Bio-Rad Laboratories With Bribery Violations"
["snippet_en"]=>
string(176) "The Securities and Exchange Commission charged Bio-Rad Laboratories , a clinical diagnostic and life-science research company, with violating the Foreign Corrupt Practices Act."
["url"]=>
string(88) "https://foxbusiness.com/markets/sec-charges-bio-rad-laboratories-with-bribery-violations"
["image_url"]=>
NULL
["source"]=>
string(15) "foxbusiness.com"
["publication_date"]=>
string(10) "2014-11-03"
["categories"]=>
array(4) {
[0]=>
string(7) "Bribery"
[1]=>
string(10) "Misconduct"
[2]=>
string(15) "Business Ethics"
[3]=>
string(11) "Regulations"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(66)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(51)
}
[2]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(31)
}
[3]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(28)
}
[4]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(26)
}
[5]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(24)
}
[6]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(23)
}
[7]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(20)
}
[8]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(19)
}
[9]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(19)
}
[11]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(18)
}
[12]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(14)
}
[13]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(14)
}
[14]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(13)
}
[15]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(13)
}
[16]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(9)
}
[17]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(9)
}
[19]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[20]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(8)
}
[21]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(7)
}
[24]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(7)
}
[25]=>
array(2) {
["name"]=>
string(16) "Case Settlements"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(15) "Business Ethics"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(5)
}
}
}
001cd-us-bio-rad-laboratories-inc
Bio-RAD Laboratories, Inc.
Location
California
Founded
1952-02-08
Website
https://www.bio-rad.com
Articles
661 Articles
Category
In Vitro and In Vivo Diagnostic Substances
Laboratory Analytical Instruments
Electromedical and Electrotherapeutic Apparatus
Description
Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together.
#Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics
A federal jury Monday awarded the former general counsel of Bio-Rad Laboratories $8 million in back pay and damages — which will increase to $11 million — for whistleblower retaliation involving potential bribery in China.
Delhi High Court rules on income tax and administrative services provided by a Singapore entity to its Indian affiliate. Analysis of the case Commissioner of Income Tax vs. Bio-Rad Laboratories.
A federal appeals court panel dealt the former general counsel for Bio-Rad Laboratories( NYSE: BIO) a blow, slicing his$ 11 million jury award by$6 million and sending his whistleblower retaliation lawsuit back to U.S. District Court for a possible
Bio-Rad has launched a range of anti-ranibizumab antibodies for PK and immunogenicity assays on the back of increased Lucentis biosimilar development. Bio-Rad Laboratories will offer customers a range of recombinant monoclonal anti-ranibizumab
The Securities and Exchange Commission charged Bio-Rad Laboratories , a clinical diagnostic and life-science research company, with violating the Foreign Corrupt Practices Act.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
